Publications by authors named "Yong-Long Liu"

Claim this Profile
P
Predictive value of nasopharyngeal microbiota for necrosis after re-irradiation in recurrent nasopharyngeal carcinoma.
Kai Wen, Ze-Rong Huang, Yong-Long Liu, Wen-Bin Wu, Zi-Han Qin, You-Ping Liu

BMC Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma.
Pei-Yu Huang, Xu-Yin Chen, Xi Ding, Ling Guo, Hao-Yuan Mo, You-Ping Liu, Si-Han Liu, Yong-Long Liu, Rong-Zeng Liu

NEJM Evid· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma.
Xiong Zou, Xi Ding, Zheng-Kai Feng, Yan-Feng Ouyang, Hui-Feng Li, You-Ping Liu, Yong-Long Liu

Cell Rep Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
Xiong Zou, Zheng-Kai Feng, Yi-Jun Hua, You-Ping Liu, Yu-Long Xie, Yong-Long Liu

Head Neck· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients.
Yong-Long Liu, Kai Wen, Wei-Jing Zhang, Yan-Feng Ouyang, Jin-Hua Chen

Otolaryngol Head Neck Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study.
Xi Ding, Yi-Jun Hua, Xiong Zou, Xiao-Zhong Chen, Xi-Mei Zhang, You-Ping Liu, Yong-Long Liu

EClinicalMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
Qi Yang, Xiong Zou, Yu-Long Xie, Chao Lin, Yan-Feng Ouyang, Yong-Long Liu, You-Ping Liu, Rong-Zeng Liu

JAMA Netw Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study.
Xi Ding, Wei-Jing Zhang, Rui You, Xiong Zou, Zhi-Qiang Wang, You-Ping Liu, Yong-Long Liu

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Rui You, You-Ping Liu, Yu-Long Xie, Chao Lin, Chong-Yang Duan, Yong-Long Liu, Rong-Zeng Liu, Li-Zhi Liu, Qing Liu

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
Rui You, Xiong Zou, Xi Ding, Wei-Jing Zhang, Meng-Xia Zhang, Yong-Long Liu, You-Ping Liu

Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.
Meng-Xia Zhang, Ting Liu, Rui You, Xiong Zou, Yong-Long Liu, You-Ping Liu

Ther Adv Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis